Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
1000577-78-5
174799-52-1
304897-49-2
361345-40-6
152193-00-5
57260-70-5
1820604-17-8 | 2,2-Dibromo-1-(2,6-dichloro-3-fluorophenyl)ethanone | AA00I0DD | MFCD26131155
1820664-86-5 | Methyl 5-bromo-3,6-dichloropyridine-2-carboxylate | AA00I0N1 | MFCD28397302
1820703-37-4 | 2-Bromo-1-methanesulfonyl-4-(trifluoromethyl)benzene | AA00I0T3 | MFCD27578181
1820739-93-2 | 2,5-Dioxopyrrolidin-1-yl 1-(trifluoromethyl)cyclobutanecarboxylate | AA00I115 | MFCD09951811
1824320-42-4 | tert-Butyl (6-bromo-3-methylpyridin-2-yl)carbamate | AA00I1AW | MFCD20923755
18501-21-8 | 1-Hydrazinopropan-2-ol oxalate | AA00I1G8 | MFCD28991778
187927-51-1 | 4-(Trifluoromethoxy)benzene-1,2-diol | AA00I1TE | MFCD29044536
189634-99-9 | N-(4-Bromo-2-cyanophenyl)acetamide | AA00I2PM | MFCD24287087
19438-60-9 | Hexahydro-4-methylphthalic anhydride | AA00I2ZD | MFCD00005927
19522-96-4 | 1,3-Benzodioxole-5-carboxaldehyde, 7-bromo- | AA00I3AK | MFCD00128258